Publications by authors named "Craig B Reeder"

Claim this Profile
M
Multi-omics analysis reveals a unique epigenetic signature in MYD88 wild-type Waldenstrom macroglobulinemia.
Karan Chohan, Jonas Paludo, Surendra Dasari, Joseph P Novak, Jithma P Abeykoon, Craig B Reeder

Haematologica· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiomics analysis of IgM monoclonal gammopathies reveals epigenetic influence on oncogenesis via DNA methylation.
Karan Chohan, Jonas Paludo, Surendra Dasari, Patrizia Mondello, Joseph P Novak, Craig B Reeder

Blood· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA and long non-coding RNA analysis in IgM-monoclonal gammopathies reveals epigenetic influence on cellular functions and oncogenesis.
Karan Chohan, Jonas Paludo, Surendra Dasari, Patrizia Mondello, Joseph P Novak, Craig B Reeder

Haematologica· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daratumumab-lenalidomide and daratumumab-pomalidomide in relapsed lenalidomide-exposed or refractory multiple myeloma.
Muhamad Alhaj Moustafa, Ricardo Parrondo, Mays F Abdulazeez, Vivek Roy, Taimur Sher, Craig B Reeder

Anticancer Drugs· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paraneoplastic morphea with prominent mucin deposition.
Ahmad B Shahin, Adina Greene, Craig B Reeder, Collin M Costello, Mark R Pittelkow

JAAD Case Rep· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma.
Julia E Wiedmeier-Nutor, Madiha Iqbal, Allison C Rosenthal, Evandro D Bezerra, Juan Esteban Garcia-Robledo, Craig B Reeder

Clin Lymphoma Myeloma Leuk· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Clusters and Tumor-Immune Drivers of IgM Monoclonal Gammopathies.
Patrizia Mondello, Jonas Paludo, Joseph P Novak, Kerstin Wenzl, Zhi-Zhang Yang, Craig B Reeder

Clin Cancer Res· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experience.
Karan L Chohan, Jonas Paludo, Nishanth Vallumsetla, Dirk Larson, Rebecca L King, Craig B Reeder

Am J Hematol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insurance-based disparities impact survival outcomes in Waldenström macroglobulinemia within the United States.
Karan L Chohan, Jithma P Abeykoon, Stephen M Ansell, Morie A Gertz, Prashant Kapoor, Craig B Reeder

Leuk Lymphoma· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update.
Eli Muchtar, Angela Dispenzieri, Morie A Gertz, Shaji K Kumar, Francis K Buadi, Craig B Reeder

Mayo Clin Proc· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment facility volume and patient outcomes in Waldenstrom macroglobulinemia.
Madugodaralalage D S K Gunaratne, Alexander J Sahakian, Jithma P Abeykoon, Stephen M Ansell, Morie A Gertz, Craig B Reeder

Leuk Lymphoma· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Direct to Drug" screening as a precision medicine tool in multiple myeloma.
Cecilia Bonolo de Campos, Nathalie Meurice, Joachim L Petit, Alysia N Polito, Yuan Xiao Zhu, Craig B Reeder

Blood Cancer J· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement.
Wilson I Gonsalves, Francis K Buadi, Sikander Ailawadhi, P Leif Bergsagel, Asher A Chanan Khan, Craig B Reeder

Bone Marrow Transplant· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Syringotropic and folliculotropic mycosis fungoides with mycosis fungoides-associated vasculopathic ulcers.
Yousif A Yonan, Helen J L Cumsky, Collin M Costello, Connor J Maly, Allison C Rosenthal, Craig B Reeder

JAAD Case Rep· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphoma.
Han W Tun, Patrick B Johnston, Lisa M DeAngelis, Pamela J Atherton, Levi D Pederson, Craig B Reeder

Blood· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab maintenance therapy for mantle cell lymphoma: A systematic review and meta-analysis.
Talal Hilal, Zhen Wang, Diana Almader-Douglas, Allison Rosenthal, Craig B Reeder

Am J Hematol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma.
Mohamad Bassam Sonbol, Talal Hilal, Amylou C Dueck, Allison C Rosenthal, Christopher R Conley, Craig B Reeder

Leuk Lymphoma· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Necrobiotic xanthogranuloma: a 30-year single-center experience.
Talal Hilal, David J DiCaudo, Suzanne M Connolly, Craig B Reeder

Ann Hematol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia.
Jonas Paludo, Jithma P Abeykoon, Amanda Shreders, Stephen M Ansell, Shaji Kumar, Craig B Reeder

Ann Hematol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment With Bortezomib-based Therapy, Followed by Autologous Stem Cell Transplantation, Improves Outcomes in Light Chain Amyloidosis: A Retrospective Study.
Tania Jain, Heidi E Kosiorek, Shu T Kung, Vishal S Shah, Amylou C Dueck, Craig B Reeder

Clin Lymphoma Myeloma Leuk· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab Maintenance Therapy After First-Line Induction Chemoimmunotherapy for Follicular Lymphoma.
Talal Hilal, Jose F Leis, Craig B Reeder

JAMA Oncol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MYD88 mutation status does not impact overall survival in Waldenström macroglobulinemia.
Jithma P Abeykoon, Jonas Paludo, Rebecca L King, Stephen M Ansell, Morie A Gertz, Craig B Reeder

Am J Hematol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial.
Nancy L Bartlett, Brian A Costello, Betsy R LaPlant, Stephen M Ansell, John G Kuruvilla, Craig B Reeder

Blood· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systolic dysfunction associated with carfilzomib use in patients with multiple myeloma.
Tania Jain, Hemalatha Narayanasamy, Joseph Mikhael, Craig B Reeder, P Leif Bergsagel

Blood Cancer J· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Observational study of lenalidomide in patients with mantle cell lymphoma who relapsed/progressed after or were refractory/intolerant to ibrutinib (MCL-004).
Michael Wang, Stephen J Schuster, Tycel Phillips, Izidore S Lossos, Andre Goy, Craig B Reeder

J Hematol Oncol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis